scholarly journals Inhomogeneous nematic-isotropic phase transition of a thermotropic liquid crystal doped with iron oxide nanoparticles

2020 ◽  
Vol 384 (36) ◽  
pp. 126927
Author(s):  
Baeckkyoung Sung ◽  
Huan Yan ◽  
Chanjoong Kim ◽  
Leon Abelmann
2015 ◽  
Vol 2 (10) ◽  
pp. 5743-5747
Author(s):  
Mussarat Fatima ◽  
Saira Riaz ◽  
Zohra Nazir Kayani ◽  
Shahzad Naseem

2019 ◽  
Vol 6 (10) ◽  
pp. 1050d2 ◽  
Author(s):  
Abhishek Kumar Misra ◽  
Pankaj Kumar Tripathi ◽  
Kamal Kumar Pandey ◽  
Fanindra Pati Pandey ◽  
Shri Singh ◽  
...  

2017 ◽  
Vol 1 (11) ◽  
pp. 2335-2340 ◽  
Author(s):  
Nurul Izza Taib ◽  
Vipul Agarwal ◽  
Nicole M. Smith ◽  
Robert C. Woodward ◽  
Timothy G. St. Pierre ◽  
...  

Grafting of PNIPAM on PGMA coated magnetic nanoparticles can be used to study the PNIPAM phase transition in solution.


2021 ◽  
Vol 22 (17) ◽  
pp. 9268
Author(s):  
Lucrezia Caselli ◽  
Marco Mendozza ◽  
Beatrice Muzzi ◽  
Alessandra Toti ◽  
Costanza Montis ◽  
...  

Hybrid materials composed of superparamagnetic iron oxide nanoparticles (SPIONs) and lipid self-assemblies possess considerable applicative potential in the biomedical field, specifically, for drug/nutrient delivery. Recently, we showed that SPIONs-doped lipid cubic liquid crystals undergo a cubic-to-hexagonal phase transition under the action of temperature or of an alternating magnetic field (AMF). This transition triggers the release of drugs embedded in the lipid scaffold or in the water channels. In this contribution, we address this phenomenon in depth, to fully elucidate the structural details and optimize the design of hybrid multifunctional carriers for drug delivery. Combining small-angle X-ray scattering (SAXS) with a magnetic characterization, we find that, in bulk lipid cubic phases, the cubic-to-hexagonal transition determines the magnetic response of SPIONs. We then extend the investigation from bulk liquid-crystalline phases to colloidal dispersions, i.e., to lipid/SPIONs nanoparticles with cubic internal structure (“magnetocubosomes”). Through Synchrotron SAXS, we monitor the structural response of magnetocubosomes while exposed to an AMF: the magnetic energy, converted into heat by SPIONs, activates the cubic-to-hexagonal transition, and can thus be used as a remote stimulus to spike drug release “on-demand”. In addition, we show that the AMF-induced phase transition in magnetocubosomes steers the realignment of SPIONs into linear string assemblies and connect this effect with the change in their magnetic properties, observed at the bulk level. Finally, we assess the internalization ability and cytotoxicity of magnetocubosomes in vitro on HT29 adenocarcinoma cancer cells, in order to test the applicability of these smart carriers in drug delivery applications.


2018 ◽  
Vol 6 (10) ◽  
Author(s):  
Hosam Zaghloul ◽  
Doaa A. Shahin ◽  
Ibrahim El- Dosoky ◽  
Mahmoud E. El-awady ◽  
Fardous F. El-Senduny ◽  
...  

Antisense oligonucleotides (ASO) represent an attractive trend as specific targeting molecules but sustain poor cellular uptake meanwhile superparamagnetic iron oxide nanoparticles (SPIONs) offer stability of ASO and improved cellular uptake. In the present work we aimed to functionalize SPIONs with ASO targeting the mRNA of Cyclin B1 which represents a potential cancer target and to explore its anticancer activity. For that purpose, four different SPIONs-ASO conjugates, S-M (1–4), were designated depending on the sequence of ASO and constructed by crosslinking carboxylated SPIONs to amino labeled ASO. The impact of S-M (1–4) on the level of Cyclin B1, cell cycle, ROS and viability of the cells were assessed by flowcytometry. The results showed that S-M3 and S-M4 reduced the level of Cyclin B1 by 35 and 36%, respectively. As a consequence to downregulation of Cyclin B1, MCF7 cells were shown to be arrested at G2/M phase (60.7%). S-M (1–4) led to the induction of ROS formation in comparison to the untreated control cells. Furthermore, S-M (1–4) resulted in an increase in dead cells compared to the untreated cells and SPIONs-treated cells. In conclusion, targeting Cyclin B1 with ASO-coated SPIONs may represent a specific biocompatible anticancer strategy.


Sign in / Sign up

Export Citation Format

Share Document